Metropolitan Life Insurance Company (MetLife)’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,881
| Closed | -$329K | – | 1391 |
|
|
2024
Q1 | $329K | Sell |
1,881
-151
| -7% | -$24.8K | 0.01% | 562 |
|
|
2023
Q4 | $342K | Sell |
2,032
-72
| -3% | -$10.5K | 0.02% | 546 |
|
|
2023
Q3 | $302K | Buy |
2,104
+156
| +8% | +$25.4K | 0.02% | 548 |
|
|
2023
Q2 | $359K | Buy |
1,948
+29
| +2% | +$4.74K | 0.02% | 510 |
|
|
2023
Q1 | $305K | Sell |
1,919
-266
| -12% | -$40.8K | 0.02% | 537 |
|
|
2022
Q4 | $297K | Buy |
2,185
+72
| +3% | +$10.1K | 0.01% | 572 |
|
|
2022
Q3 | $244K | Hold |
2,113
| – | – | 0.01% | 603 |
|
|
2022
Q2 | $256K | Sell |
2,113
-90
| -4% | -$11.3K | 0.01% | 620 |
|
|
2022
Q1 | $313K | Sell |
2,203
-6,697
| -75% | -$950K | 0.01% | 633 |
|
|
2021
Q4 | $1.57M | Sell |
8,900
-258
| -3% | -$43.1K | 0.02% | 669 |
|
|
2021
Q3 | $1.41M | Sell |
9,158
-304
| -3% | -$44.2K | 0.02% | 719 |
|
|
2021
Q2 | $1.28M | Buy |
9,462
+611
| +7% | +$82.2K | 0.02% | 822 |
|
|
2021
Q1 | $1.17M | Sell |
8,851
-842
| -9% | -$111K | 0.02% | 840 |
|
|
2020
Q4 | $1.15M | Sell |
9,693
-128
| -1% | -$14.9K | 0.02% | 787 |
|
|
2020
Q3 | $1.03M | Sell |
9,821
-557
| -5% | -$58.9K | 0.02% | 728 |
|
|
2020
Q2 | $1.11M | Buy |
10,378
+301
| +3% | +$28K | 0.02% | 675 |
|
|
2020
Q1 | $805K | Buy |
10,077
+63
| +0.6% | +$5.63K | 0.02% | 794 |
|
|
2019
Q4 | $886K | Sell |
10,014
-798
| -7% | -$68.8K | 0.01% | 963 |
|
|
2019
Q3 | $884K | Buy |
10,812
+818
| +8% | +$66.5K | 0.02% | 924 |
|
|
2019
Q2 | $942K | Buy |
9,994
+82
| +0.8% | +$7K | 0.02% | 933 |
|
|
2019
Q1 | $840K | Sell |
9,912
-876
| -8% | -$65.8K | 0.02% | 977 |
|
|
2018
Q4 | $680K | Buy |
10,788
+261
| +2% | +$16.8K | 0.01% | 1020 |
|
|
2018
Q3 | $720K | Hold |
10,527
| – | – | 0.01% | 1113 |
|
|
2018
Q2 | $656K | Buy |
10,527
+943
| +10% | +$57.7K | 0.01% | 1134 |
|
|
2018
Q1 | $500K | Sell |
9,584
-810
| -8% | -$44.4K | 0.01% | 1274 |
|
|
2017
Q4 | $520K | Sell |
10,394
-11,767
| -53% | -$573K | 0.01% | 1265 |
|
|
2017
Q3 | $966K | Hold |
22,161
| – | – | 0.01% | 1276 |
|
|
2017
Q2 | $798K | Buy |
22,161
+666
| +3% | +$21.1K | 0.01% | 1374 |
|
|
2017
Q1 | $571K | Buy |
21,495
+798
| +4% | +$19.5K | ﹤0.01% | 1561 |
|
|
2016
Q4 | $435K | Sell |
20,697
-818
| -4% | -$15.6K | ﹤0.01% | 1834 |
|
|
2016
Q3 | $373K | Sell |
21,515
-5,441
| -20% | -$89.6K | ﹤0.01% | 1898 |
|
|
2016
Q2 | $408K | Buy |
+26,956
| New | +$414K | ﹤0.01% | 1828 |
|
Other funds holding NOVT
CCA
WA
Metropolitan Life Insurance Company (MetLife)'s NOVT Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Novanta (NOVT) in Q2 2024, closing a stake of 1,881 shares — an estimated $329K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NOVT in Q2 2016 and held it in 32 quarters. The position peaked at $1.57M in Q4 2021. 270 funds tracked by Wall St. Rank hold NOVT as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Novanta position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,881 Novanta shares in Q2 2024, an estimated $329K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Novanta in Q2 2016 and held it in 32 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Novanta position peaked at $1.57M in Q4 2021.
- 270 funds tracked by Wall St. Rank held Novanta as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.